• Publications
  • Influence
Gynecologic oncology
OBJECTIVES: Caelyx is a novel pegylated liposomal doxorubicin formulation and has been approved for the treatment of recurrent ovarian cancer. METHODS: We performed a multi-institutional phase-IIExpand